Co-Authors
This is a "connection" page, showing publications co-authored by Tareq Kass-Hout and James Siegler.
Connection Strength
2.363
-
Comparing validated stroke screening scales for identifying large and medium vessel occlusions: a prospective observational cohort study. J Neurointerv Surg. 2025 Jan 27.
Score: 0.248
-
Fourth-generation Pipeline™ Vantage flow diversion: First reported US experience of safety and feasibility. Interv Neuroradiol. 2024 Dec 05; 15910199241301119.
Score: 0.245
-
The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience. J Neurointerv Surg. 2024 Nov 22; 16(12):1244-1249.
Score: 0.245
-
Endovascular thrombectomy for distal medium vessel occlusions: A literature review. J Stroke Cerebrovasc Dis. 2025 Jan; 34(1):108134.
Score: 0.244
-
Use of Onyx Frontier™ for intracranial stenting in stroke patients: A multicenter retrospective study. Interv Neuroradiol. 2024 Oct 21; 15910199241286922.
Score: 0.243
-
Early single-center experience with middle meningeal artery embolization using Zoom™ 45 Catheter. Interv Neuroradiol. 2024 May 06; 15910199241250078.
Score: 0.236
-
Endovascular Thrombectomy with or without Bridging Thrombolysis in Acute Ischemic Stroke: A Cost-Effectiveness Analysis. Neuroepidemiology. 2024; 58(1):47-56.
Score: 0.230
-
Intravenous cangrelor use for neuroendovascular procedures: a two-center experience and updated systematic review. Front Neurol. 2023; 14:1304599.
Score: 0.229
-
Real-World Outcomes for Basilar Artery Occlusion Thrombectomy With Mild Deficits: The National Inpatient Sample. Stroke. 2023 08; 54(8):2031-2039.
Score: 0.222
-
Intravenous Thrombolysis in Patients With Cervical Artery Dissection: A Secondary Analysis of the STOP-CAD Study. Neurology. 2024 Oct 08; 103(7):e209843.
Score: 0.060
-
Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study. Stroke. 2024 Apr; 55(4):908-918.
Score: 0.058
-
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study. Neurology. 2022 11 22; 99(21):e2368-e2377.
Score: 0.053
-
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022 03; 53(3):728-738.
Score: 0.050